Building Programs to Eradicate Toxoplasmosis Part III: Epidemiology and Risk Factors

03 medical and health sciences 0302 clinical medicine Article 3. Good health
DOI: 10.1007/s40124-022-00265-0 Publication Date: 2022-06-22T05:03:46Z
AUTHORS (139)
ABSTRACT
AbstractPurpose of ReviewReview comprehensive data on rates of toxoplasmosis in Panama and Colombia.Recent FindingsSamples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of antibodies toToxoplasmaand risk factors, were reviewed.SummaryScreening maps, seroprevalence maps, and risk factor mathematical models were devised based on these data. Studies in Ciudad de Panamá estimated seroprevalence at between 22 and 44%. Consistent relationships were found between higher prevalence rates and factors such as poverty and proximity to water sources. Prenatal screening rates for anti-Toxoplasmaantibodies were variable, despite existence of a screening law. Heat maps showed a correlation between proximity to bodies of water and overallToxoplasmaseroprevalence. Spatial epidemiological maps and mathematical models identify specific regions that could most benefit from comprehensive, preventive healthcare campaigns related to congenital toxoplasmosis andToxoplasmainfection.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (17)
CITATIONS (3)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....